litlas
Log inCreate account

Ignacio I. Wistuba

Active 1992–2025

465
Papers
92,502
Citations
155
h-index
442
i10-index

Citations

Citations per year for Ignacio I. Wistuba1951: 1 citations1963: 1 citations1970: 1 citations1971: 4 citations1976: 2 citations1978: 1 citations1985: 1 citations1986: 1 citations1990: 1 citations1993: 2 citations1994: 1 citations1995: 3 citations1996: 2 citations1997: 5 citations1998: 37 citations1999: 83 citations2000: 99 citations2001: 142 citations2002: 152 citations2003: 150 citations2004: 90 citations2005: 126 citations2006: 144 citations2007: 151 citations2008: 299 citations2009: 346 citations2010: 424 citations2011: 475 citations2012: 533 citations2013: 573 citations2014: 609 citations2015: 678 citations2016: 856 citations2017: 902 citations2018: 1,058 citations2019: 3,486 citations2020: 4,377 citations2021: 4,788 citations2022: 4,026 citations2023: 3,295 citations2024: 4,740 citations2025: 2,630 citations2026: 99 citations1952–1962: no citations, so these years are not shown1964–1969: no citations, so these years are not shown1972–1975: no citations, so these years are not shown1977: no citations, so this year is not shown1979–1984: no citations, so these years are not shown1987–1989: no citations, so these years are not shown1991–1992: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 10,881 citing papers, 26% of this breakdownChina: 8,002 citing papers, 19.1% of this breakdownUnited Kingdom: 1,997 citing papers, 4.8% of this breakdownItaly: 1,902 citing papers, 4.5% of this breakdownJapan: 1,658 citing papers, 4% of this breakdownGermany: 1,649 citing papers, 3.9% of this breakdownFrance: 1,384 citing papers, 3.3% of this breakdownCanada: 1,118 citing papers, 2.7% of this breakdownSpain: 1,114 citing papers, 2.7% of this breakdownSouth Korea: 991 citing papers, 2.4% of this breakdownAustralia: 938 citing papers, 2.2% of this breakdownNetherlands: 876 citing papers, 2.1% of this breakdown
0%26%Other 22.3%

Institutions

Fields

  • Medicine56.1%
  • Biochemistry, Genetics and Molecular Biology33.1%
  • Immunology and Microbiology5.6%
  • Computer Science1.6%
  • Engineering1%
  • Neuroscience0.7%
  • Other1.9%

Topics

  • Cancer Immunotherapy and Biomarkers7.2%
  • Lung Cancer Treatments and Mutations5.8%
  • Cancer Genomics and Diagnostics3.8%
  • Lung Cancer Diagnosis and Treatment3.4%
  • Lung Cancer Research Studies3.4%
  • Immunotherapy and Immune Responses2.6%
  • Other73.8%

Coauthors

All papers

Open in search
  1. PD-L1 as a biomarker of response to immune-checkpoint inhibitors

    Authors: Deborah B. Doroshow, Sheena Bhalla, Mary Beth Beasley, Lynette M. Sholl, Keith M. Kerr, Sacha Gnjatic, Ignacio I. Wistuba, David L. Rimm, Ming‐Sound Tsao, Fred R. Hirsch - Nature Reviews Clinical Oncology 2021 cited by 1,560

  2. The 2015 World Health Organization Classification of Lung Tumors

    Authors: William D. Travis, Élisabeth Brambilla, Andrew G. Nicholson, Yasushi Yatabe, John H. M. Austin, Mary Beth Beasley, Lucian R. Chirieac, Sanja Đačić, Edwina Duhig, Douglas B. Flieder, Kim R. Geisinger, Fred R. Hirsch, Yuichi Ishikawa, Keith M. Kerr, Masayuki Noguchi, Giuseppe Pelosi, Charles A. Powell, Ming‐Sound Tsao, Ignacio I. Wistuba - Journal of Thoracic Oncology 2015 cited by 4,546

  3. Patterns of transcription factor programs and immune pathway activation define four major subtypes of SCLC with distinct therapeutic vulnerabilities

    Authors: Carl M. Gay, C. Allison Stewart, Elizabeth M. Park, Lixia Diao, Sarah M. Groves, Simon Heeke, Barzin Y. Nabet, Junya Fujimoto, Luisa M. Solis, Wei Lü, Yuanxin Xi, Robert J. Cardnell, Qi Wang, Giulia Fabbri, Kasey R. Cargill, Natalie I. Vokes, Kavya Ramkumar, Bingnan Zhang, Carminia Maria Della Corte, Paul Robson, Stephen G. Swisher, Jack A. Roth, Bonnie S. Glisson, David S. Shames, Ignacio I. Wistuba, Jing Wang, Vito Quaranta, John D. Minna, John V. Heymach, Lauren A. Byers - Cancer Cell 2021 cited by 932

  4. STK11/LKB1 Mutations and PD-1 Inhibitor Resistance in KRAS-Mutant Lung Adenocarcinoma

    Authors: Ferdinandos Skoulidis, Michael E. Goldberg, Danielle Greenawalt, Matthew D. Hellmann, Mark M. Awad, Justin F. Gainor, Alexa B. Schrock, Ryan J. Hartmaier, Sally E. Trabucco, Laurie M. Gay, Siraj M. Ali, Julia A. Elvin, Gaurav Singal, Jeffrey S. Ross, David Fabrizio, Péter M. Szabó, Chang Han, Ariella Sasson, Sujaya Srinivasan, Stefan Kirov, Joseph D. Szustakowski, Patrik Vitazka, Robin Edwards, José A. Bufill, Neelesh Sharma, Sai‐Hong Ignatius Ou, Nir Peled, David R. Spigel, Hira Rizvi, Elizabeth Jiménez Aguilar, Brett W. Carter, Jeremy Erasmus, Darragh Halpenny, Andrew J. Plodkowski, Niamh M. Long, Mizuki Nishino, Warren L. Denning, Ana Galán‐Cobo, Haïfa Hamdi, Taghreed Hirz, Pan Tong, Jing Wang, Jaime Rodriguez‐Canales, Pamela Villalobos, Edwin R. Parra, Neda Kalhor, Lynette M. Sholl, Jennifer L. Sauter, Achim A. Jungbluth, Mari Mino–Kenudson, Roxana Azimi, Yasir Y. Elamin, Jianjun Zhang, Giulia C. Leonardi, Fei Jiang, Kwok‐Kin Wong, J. Jack Lee, Vassiliki A. Papadimitrakopoulou, Ignacio I. Wistuba, Vincent A. Miller, Garrett M. Frampton, Jedd D. Wolchok, Alice T. Shaw, Pasi A. Jänne, Philip J. Stephens, Charles M. Rudin, William J. Geese, Lee A. Albacker, John V. Heymach - Cancer Discovery 2018 cited by 1,604

  5. Targeting DNA Damage Response Promotes Antitumor Immunity through STING-Mediated T-cell Activation in Small Cell Lung Cancer

    Authors: Triparna Sen, B. Leticia Rodriguez, Limo Chen, Carminia Maria Della Corte, Naoto Morikawa, Junya Fujimoto, Sandra Cristea, Thuyen Nguyen, Lixia Diao, Lerong Li, You-Hong Fan, Yongbin Yang, Jing Wang, Bonnie S. Glisson, Ignacio I. Wistuba, Julien Sage, John V. Heymach, Don L. Gibbons, Lauren A. Byers - Cancer Discovery 2019 cited by 881

  6. Cancer biomarkers: Emerging trends and clinical implications for personalized treatment

    Authors: Antonio Passaro, Maise Al Bakir, Emily G. Hamilton, Maximilian Diehn, Fabrice André, Sinchita Roy‐Chowdhuri, Giannis Mountzios, Ignacio I. Wistuba, Charles Swanton, Solange Peters - Cell 2024 cited by 627

  7. International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma

    Authors: William D. Travis, Élisabeth Brambilla, Masayuki Noguchi, Andrew G. Nicholson, Kim R. Geisinger, Yasushi Yatabe, David G. Beer, Charles A. Powell, Gregory J. Riely, Paul E. Van Schil, Kavita Garg, John H. M. Austin, Hisao Asamura, Valerie W. Rusch, Fred R. Hirsch, Giorgio V. Scagliotti, Tetsuya Mitsudomi, Rudolf M. Huber, Yuichi Ishikawa, James R. Jett, Montse Sánchez‐Céspedes, Jean‐Paul Sculier, Takashi Takahashi, Masahiro Tsuboi, Johan Vansteenkiste, Ignacio I. Wistuba, Pan‐Chyr Yang, Denise R. Aberle, Christian Brambilla, Douglas B. Flieder, Wilbur A. Franklin, Adi F. Gazdar, Michael K. Gould, P S Hasleton, Douglas W. Henderson, Bruce Johnson, David Johnson, Keith M. Kerr, Keiko Kuriyama, Jin Soo Lee, Vincent A. Miller, Iver Petersen, Victor L. Roggli, Rafael Rosell, Nagahiro Saijo, Erik Thunnissen, Ming‐Sound Tsao, David Yankelewitz - Journal of Thoracic Oncology 2011 cited by 4,843

  8. Pembrolizumab in advanced soft-tissue sarcoma and bone sarcoma (SARC028): a multicentre, two-cohort, single-arm, open-label, phase 2 trial

    Authors: Hussein A. Tawbi, Melissa Burgess, Vanessa Bolejack, Brian A. Van Tine, Scott M. Schuetze, James Hu, Sandra P. D’Angelo, Steven Attia, Richard F. Riedel, Dennis A. Priebat, Sujana Movva, Lara E. Davis, Scott H. Okuno, Damon R. Reed, John Crowley, Lisa H. Butterfield, Ruth Salazar, Jaime Rodriguez‐Canales, Alexander J. Lazar, Ignacio I. Wistuba, Laurence H. Baker, Robert G. Maki, Denise K. Reinke, Shreyaskumar Patel - The Lancet Oncology 2017 cited by 1,423

  9. Neoadjuvant chemotherapy and nivolumab in resectable non-small-cell lung cancer (NADIM): an open-label, multicentre, single-arm, phase 2 trial

    Authors: Mariano Provencio, Ernest Nadal, Amelia Insa, María Rosario García-Campelo, Joaquín Casal‐Rubio, Manuel Dómine, Margarita Majem, Delvys Rodríguez‐Abreu, Alex Martínez‐Martí, Javier de Castro, Manuel Cobo, Guillermo López-Vivanco, E. del Barco, Reyes Bernabé Caro, Núria Viñolas, Isidoro Barneto Aranda, Santiago Viteri, Eva Pereira, Ana Royuela, Marta Casarrubios, Clara Salas, Edwin R. Parra, Ignacio I. Wistuba, Virginia Calvo, Raquel Laza‐Briviesca, Atocha Romero, Bartomeu Massutí, Alberto Cruz‐Bermúdez - The Lancet Oncology 2020 cited by 828

  10. Liquid Biopsy for Advanced NSCLC: A Consensus Statement From the International Association for the Study of Lung Cancer

    Authors: Christian Rolfo, Philip C. Mack, Giorgio V. Scagliotti, Charu Aggarwal, Maria E. Arcila, Fabrice Barlési, Trever G. Bivona, Maximilian Diehn, Caroline Dive, Rafał Dziadziuszko, Natasha B. Leighl, Umberto Malapelle, Tony Mok, Nir Peled, Luis E. Raez, Lecia V. Sequist, Lynette M. Sholl, Charles Swanton, Chris Abbosh, Daniel S.W. Tan, Heather A. Wakelee, Ignacio I. Wistuba, Rebecca A. Bunn, Janet Freeman‐Daily, Murry W. Wynes, Chandra P. Belani, Tetsuya Mitsudomi, David R. Gandara - Journal of Thoracic Oncology 2021 cited by 645

  11. Collagen promotes anti-PD-1/PD-L1 resistance in cancer through LAIR1-dependent CD8+ T cell exhaustion

    Authors: David H. Peng, B. Leticia Rodriguez, Lixia Diao, Limo Chen, Jing Wang, Lauren A. Byers, Ying Wei, Harold A. Chapman, Mitsuo Yamauchi, Carmen Behrens, Gabriela Raso, Luisa M. Solis Soto, Edwin R. Parra, Ignacio I. Wistuba, Jonathan M. Kurie, Don L. Gibbons - Nature Communications 2020 cited by 446

  12. Co-occurring Genomic Alterations Define Major Subsets of KRAS -Mutant Lung Adenocarcinoma with Distinct Biology, Immune Profiles, and Therapeutic Vulnerabilities

    Authors: Ferdinandos Skoulidis, Lauren A. Byers, Lixia Diao, Vassiliki A. Papadimitrakopoulou, Pan Tong, Julie Izzo, Carmen Behrens, Humam Kadara, Edwin R. Parra, Jaime Rodriguez Canales, Jianjun Zhang, Uma Giri, Jayanthi Gudikote, María Angélica Cortez, Chao Yang, You-Hong Fan, Michael Peyton, Luc Girard, Kevin R. Coombes, Carlo Toniatti, Timothy P. Heffernan, Murim Choi, Garrett M. Frampton, Vincent A. Miller, John N. Weinstein, Roy S. Herbst, Kwok‐Kin Wong, Jianhua Zhang, Padmanee Sharma, Gordon B. Mills, Waun Ki Hong, John D. Minna, James P. Allison, P. Andrew Futreal, Jing Wang, Ignacio I. Wistuba, John V. Heymach - Cancer Discovery 2015 cited by 916

  13. Analysis of Immune Signatures in Longitudinal Tumor Samples Yields Insight into Biomarkers of Response and Mechanisms of Resistance to Immune Checkpoint Blockade

    Authors: Pei-Ling Chen, Whijae Roh, Alexandre Reuben, Zachary A. Cooper, Christine N. Spencer, Peter A. Prieto, John P. Miller, Roland L. Bassett, Vancheswaran Gopalakrishnan, Khalida Wani, Mariana Petaccia de Macêdo, Jacob L. Austin-Breneman, Hong Jiang, Qing Chang, Sangeetha M. Reddy, Wei-Shen Chen, Michael T. Tetzlaff, Russell J. Broaddus, Michael A. Davies, Jeffrey E. Gershenwald, Lauren E. Haydu, Alexander J. Lazar, Sapna P. Patel, Patrick Hwu, Wen-Jen Hwu, Adi Diab, Isabella C. Glitza, Scott E. Woodman, Luis M. Vence, Ignacio I. Wistuba, Rodabe N. Amaria, Lawrence N. Kwong, Víctor G. Prieto, R. Eric Davis, Wencai Ma, Willem W. Overwijk, Arlene H. Sharpe, Jianhua Hu, P. Andrew Futreal, Jorge Blando, Padmanee Sharma, James P. Allison, Lynda Chin, Jennifer A. Wargo - Cancer Discovery 2016 cited by 1,008

  14. Phase I Study of DNX-2401 (Delta-24-RGD) Oncolytic Adenovirus: Replication and Immunotherapeutic Effects in Recurrent Malignant Glioma

    Authors: Frederick F. Lang, Charles A. Conrad, Candelaria Gomez‐Manzano, W. K. Alfred Yung, Raymond Sawaya, Jeffrey S. Weinberg, Sujit S. Prabhu, Ganesh Rao, Gregory N. Fuller, Kenneth Aldape, Joy Gumin, Luis M. Vence, Ignacio I. Wistuba, Jaime Rodriguez‐Canales, Pamela Villalobos, Clemens M.F. Dirven, Sonia Tejada, Ricardo Díez Valle, Marta M. Alonso, Brett Ewald, Joanna Peterkin, Frank Tufaro, Juàn Fueyo - Journal of Clinical Oncology 2018 cited by 708

  15. Increased Tumor Glycolysis Characterizes Immune Resistance to Adoptive T Cell Therapy

    Authors: Tina Cascone, Jodi A. McKenzie, Rina M. Mbofung, Simone Punt, Zhe Wang, Chunyu Xu, Leila J. Williams, Zhiqiang Wang, Christopher A. Bristow, Alessandro Carugo, Michael Peoples, Lerong Li, Tatiana V. Karpinets, Lu Huang, Shruti Malu, Caitlin Creasy, Sara Elizabeth Leahey, Jiong Chen, Yuan Chen, Helen Pelicano, Chantale Bernatchez, Y.N. Vashisht Gopal, Timothy P. Heffernan, Jianhua Hu, Jing Wang, Rodabe N. Amaria, Levi A. Garraway, Peng Huang, Peiying Yang, Ignacio I. Wistuba, Scott E. Woodman, Jason Roszik, R. Eric Davis, Michael A. Davies, John V. Heymach, Patrick Hwu, Weiyi Peng - Cell Metabolism 2018 cited by 624

  16. STK11/LKB1 Deficiency Promotes Neutrophil Recruitment and Proinflammatory Cytokine Production to Suppress T-cell Activity in the Lung Tumor Microenvironment

    Authors: Shohei Koyama, Esra A. Akbay, Yvonne Y. Li, Amir Reza Aref, Ferdinandos Skoulidis, Grit S. Herter-Sprie, Kevin A. Buczkowski, Yan Liu, Mark M. Awad, Warren L. Denning, Lixia Diao, Jing Wang, Edwin R. Parra-Cuentas, Ignacio I. Wistuba, Margaret Soucheray, Tran C. Thai, Hajime Asahina, Shunsuke Kitajima, Abigail Altabef, Jillian D. Cavanaugh, Kevin Rhee, Peng Gao, Haikuo Zhang, Peter E. Fecci, Takeshi Shimamura, Matthew D. Hellmann, John V. Heymach, F. Stephen Hodi, Gordon J. Freeman, David A. Barbie, Glenn Dranoff, Peter S. Hammerman, Kwok‐Kin Wong - Cancer Research 2016 cited by 630

  17. Neoadjuvant chemotherapy plus nivolumab with or without ipilimumab in operable non-small cell lung cancer: the phase 2 platform NEOSTAR trial

    Authors: Tina Cascone, Cheuk Hong Leung, Annikka Weissferdt, Apar Pataer, Brett W. Carter, Myrna C. B. Godoy, Hope Feldman, William N. William, Yuanxin Xi, Sreyashi Basu, Jing Sun, Shalini S. Yadav, Frank Rojas Alvarez, Younghee Lee, Aditya K. Mishra, Lili Chen, Monika Pradhan, Haiping Guo, Ansam Sinjab, Nicolas Zhou, Marcelo V. Negrão, Xiuning Le, Carl M. Gay, Anne S. Tsao, Lauren A. Byers, Mehmet Altan, Bonnie S. Glisson, Frank V. Fossella, Yasir Y. Elamin, George Blumenschein, Jianjun Zhang, Ferdinandos Skoulidis, Jia Wu, Reza J. Mehran, David C. Rice, Garrett L. Walsh, Wayne L. Hofstetter, Ravi Rajaram, Mara B. Antonoff, Junya Fujimoto, Luisa M. Solis, Edwin R. Parra, Cara Haymaker, Ignacio I. Wistuba, Stephen G. Swisher, Ara A. Vaporciyan, Heather Lin, Jing Wang, Don L. Gibbons, J. Jack Lee, Nadim J. Ajami, Jennifer A. Wargo, James P. Allison, Padmanee Sharma, Humam Kadara, John V. Heymach, Boris Sepesi - Nature Medicine 2023 cited by 206

  18. MCT4-dependent lactate secretion suppresses antitumor immunity in LKB1-deficient lung adenocarcinoma

    Authors: Yu Qian, Ana Galán‐Cobo, Irene Guijarro, Minghao Dang, David Molkentine, Alissa Poteete, Fahao Zhang, Qi Wang, Jing Wang, Edwin R. Parra, Apekshya Panda, Jacy Fang, Ferdinandos Skoulidis, Ignacio I. Wistuba, Svena Verma, Taha Merghoub, Jedd D. Wolchok, Kwok‐Kin Wong, Ralph J. DeBerardinis, John D. Minna, Natalie I. Vokes, Catherine B. Meador, Justin F. Gainor, Linghua Wang, Alexandre Reuben, John V. Heymach - Cancer Cell 2023 cited by 178

  19. A Grading System for Invasive Pulmonary Adenocarcinoma: A Proposal From the International Association for the Study of Lung Cancer Pathology Committee

    Authors: André L. Moreira, Paolo Ocampo, Yuhe Xia, Judy Zhong, Prudence A. Russell, Yuko Minami, Wendy A. Cooper, Akihiko Yoshida, Lukas Bubendorf, Mauro Papotti, Giuseppe Pelosi, Fernando López‐Ríos, Keiko Kunitoki, Dana Ferrari‐Light, Lynette M. Sholl, Mary Beth Beasley, Alain Borczuk, Johan Botling, Élisabeth Brambilla, Gang Chen, Teh‐Ying Chou, Jin-Haeng Chung, Sanja Đačić, Deepali Jain, Fred R. Hirsch, David Hwang, Sylvie Lantuéjoul, Dongmei Lin, John Longshore, Noriko Motoi, Masayuki Noguchi, Claudia Poleri, Natasha Rekhtman, Ming‐Sound Tsao, Erik Thunnissen, William D. Travis, Yasushi Yatabe, Anja C. Roden, Jillian B. Daigneault, Ignacio I. Wistuba, Keith M. Kerr, Harvey I. Pass, Andrew G. Nicholson, Mari Mino–Kenudson - Journal of Thoracic Oncology 2020 cited by 541

  20. NRF2 regulates serine biosynthesis in non–small cell lung cancer

    Authors: Gina M. DeNicola, Pei-Hsuan Chen, Edouard Mullarky, Jessica Sudderth, Zeping Hu, David Wu, Hao Tang, Yang Xie, John M. Asara, Kenneth E. Huffman, Ignacio I. Wistuba, John D. Minna, Ralph J. DeBerardinis, Lewis C. Cantley - Nature Genetics 2015 cited by 778

  21. Removal of N-Linked Glycosylation Enhances PD-L1 Detection and Predicts Anti-PD-1/PD-L1 Therapeutic Efficacy

    Authors: Heng‐Huan Lee, Ying‐Nai Wang, Weiya Xia, Chia‐Hung Chen, Kun-Ming Rau, Leiguang Ye, Yongkun Wei, Chao‐Kai Chou, Shao‐Chun Wang, Meisi Yan, Chih‐Yen Tu, Te‐Chun Hsia, Shu‐Fen Chiang, K. S. Clifford Chao, Ignacio I. Wistuba, Jennifer L. Hsu, Gabriel N. Hortobágyi, Mien‐Chie Hung - Cancer Cell 2019 cited by 413

  22. VISTA is an inhibitory immune checkpoint that is increased after ipilimumab therapy in patients with prostate cancer

    Authors: Jianjun Gao, John F. Ward, Curtis A. Pettaway, Lewis Z. Shi, Sumit K. Subudhi, Luis M. Vence, Hao Zhao, Jianfeng Chen, Hong Chen, Eleni Efstathiou, Patricia Troncoso, James P. Allison, Christopher J. Logothetis, Ignacio I. Wistuba, Manuel A. Sepúlveda, Jingjing Sun, Jennifer A. Wargo, Jorge Blando, Padmanee Sharma - Nature Medicine 2017 cited by 592

  23. Using Multiplexed Assays of Oncogenic Drivers in Lung Cancers to Select Targeted Drugs

    Authors: Mark G. Kris, Bruce E. Johnson, Lynne D. Berry, David J. Kwiatkowski, A. John Iafrate, Ignacio I. Wistuba, Marileila Varella‐Garcia, Wilbur A. Franklin, Samuel L. Aronson, Pei-Fang Su, Yu Shyr, D. Ross Camidge, Lecia V. Sequist, Bonnie S. Glisson, Fadlo R. Khuri, Edward B. Garon, William Pao, Charles M. Rudin, Joan H. Schiller, Eric B. Haura, Mark A. Socinski, Keisuke Shirai, Heidi Chen, Giuseppe Giaccone, Marc Ladanyi, Kelly Kugler, John D. Minna, Paul A. Bunn - JAMA 2014 cited by 1,744

  24. Single-cell analyses reveal increased intratumoral heterogeneity after the onset of therapy resistance in small-cell lung cancer

    Authors: C. Allison Stewart, Carl M. Gay, Yuanxin Xi, Santhosh Sivajothi, V. Sivakamasundari, Junya Fujimoto, Mohan Bolisetty, Patrice M. Hartsfield, Veerakumar Balasubramaniyan, Milind D. Chalishazar, César A. Moran, Neda Kalhor, John Stewart, Hai T. Tran, Stephen G. Swisher, Jack A. Roth, Jianjun Zhang, John de Groot, Bonnie S. Glisson, Trudy G. Oliver, John V. Heymach, Ignacio I. Wistuba, Paul Robson, Jing Wang, Lauren A. Byers - Nature Cancer 2020 cited by 372